产前微阵列分析发现的偶然发现及加泰罗尼亚公共卫生网络XIGENICS共识报告标准
该研究回顾性分析了2018至2023年加泰罗尼亚公共卫生系统六个中心连续完成的4219例产前微阵列,检出69个偶然发现(检出率1.6%),并制定共识报告建议以标准化报告。长期随访显示高外显率神经易感性CNV的新生儿更常出现临床表现。按新共识标准,43个偶然发现将被报告,17个不报告,9个取决于父母决定。
要点
- 产前微阵列偶然发现检出率为1.6%(69/4219),高于既往认知。
- 偶然发现包括完全外显率神经发育障碍/先天缺陷CNV、不完全外显率CNV、可预防或治疗疾病、非儿童期起病神经系统疾病、X连锁疾病及SHOX基因缺失。
- 按新共识标准,43个偶然发现将报告,17个不报告,9个取决于父母决定。
核心结论
- 该研究是迄今最大系列严格记录连续妊娠微阵列评估中所有偶然发现(包括已报告和未报告)的研究。
- 偶然发现检出频率高于既往认知,强调需要特定的临床关注。
- 制定了全面的共识报告建议以确保标准统一,并成立了特设委员会管理复杂病例。
研究设计与样本
- 回顾性审查2018至2023年加泰罗尼亚公共卫生系统六个中心(XIGENICS网络)连续完成的4219例产前微阵列,涵盖所有转诊原因。
- 通过多次讨论会议及广泛文献综述制定共识建议。
主要发现
- 在68份样本中检出69个偶然发现,检出率为1.6%。
- 偶然发现包括:5个与完全外显率神经发育障碍和/或先天缺陷相关的CNV,41个与不完全外显率神经发育障碍和/或先天缺陷相关的CNV,4种可潜在预防或治疗的疾病,5种非儿童期起病神经系统疾病,13种X连锁疾病(主要为STS和DMD缺失),以及1个SHOX基因缺失。
- 长期随访显示,携带高外显率神经易感性CNV的新生儿比携带低外显率CNV的新生儿更常出现临床表现。
- 报告时,52个偶然发现被披露,17个未被披露。
- 按新共识标准,43个偶然发现将被报告,17个将不报告,9个将取决于父母决定。
关键数值与推荐
- 按新共识标准,43个偶然发现将被报告,17个将不报告,9个将取决于父母决定。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study aimed to evaluate the frequency of pathogenic copy number variants (CNVs) classified as incidental findings (IFs) in prenatal diagnosis and to develop consensus recommendations for standardizing their reporting across six centers within the Catalan public health system (XIGENICS network). METHOD: A retrospective review of 4219 consecutive prenatal microarrays performed within the network from 2018 to 2023 was conducted, including all referral reasons. To develop consensus recommendations, several discussion meetings were held along with an extensive review of the existing literature. RESULTS: A total of 69 IFs were identified in 68 samples, revealing a detection rate of 1.6%. They included: 5 CNVs associated with neurodevelopmental disorders and/or congenital defects with complete penetrance, 41 CNVs for neurodevelopmental disorders and/or congenital defects with incomplete penetrance, 4 disorders that can potentially be prevented or treated, 5 non-childhood onset neurological disorders, 13 X-linked disorders (mainly STS and DMD deletions), and 1 deletion of the SHOX gene. Long-term follow-up revealed that newborns with high penetrance neurosusceptibility CNVs exhibited clinical manifestations more frequently than those with low penetrance CNVs. At the time of reporting, 52 IFs were disclosed, while 17 were not. According to the new consensus criteria, 43 IFs would now be reported, 17 would not, and 9 would depend on parental decision. CNVs consistent with the referral reason were identified in 4% of cases. CONCLUSION: This study represents the largest series rigorously documenting all identified IFs in consecutive pregnancies evaluated by microarray, including both reported and unreported findings. IFs were found at a higher frequency than previously recognized, underscoring the need for specific clinical attention. Comprehensive consensus reporting recommendations were developed to ensure uniformity of criteria, and an ad hoc committee was established to manage complex cases.
引用
- Mademont-Soler I, Castells-Sarret N, Cisneros A, et al. Incidental Findings Identified by Prenatal Microarray Analysis and Consensus Reporting Criteria of the Catalan Public Health Network XIGENICS. Prenat Diagn. 2025. PMID: 39815072. doi:10.1002/pd.6746
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。